Unknown

Dataset Information

0

Long-Term Humoral Immune Response in Persons with Asymptomatic or Mild SARS-CoV-2 Infection, Vietnam.

ABSTRACT: Antibody response against nucleocapsid and spike proteins of SARS-CoV-2 in 11 persons with mild or asymptomatic infection rapidly increased after infection. At weeks 18-30 after diagnosis, all remained seropositive but spike protein-targeting antibody titers declined. These data may be useful for vaccine development.

SUBMITTER: Mai HK 

PROVIDER: S-EPMC7853537 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Flow cytometry detection of sustained humoral immune response (IgG + IgA) against native spike glycoprotein in asymptomatic/mild SARS-CoV-2 infection.
| S-EPMC8140089 | biostudies-literature
Unknown SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection.
| S-EPMC8754314 | biostudies-literature
Unknown Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals.
| S-EPMC8484961 | biostudies-literature
Unknown Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.
| S-EPMC7772470 | biostudies-literature
Unknown Humoral Immune Response to SARS-CoV-2 in Iceland.
| S-EPMC7494247 | biostudies-literature
Unknown Short-term perioperative outcomes among patients with concurrent asymptomatic and mild SARS-CoV-2 infection: A retrospective, multicenter study
| S-EPMC8716176 | biostudies-literature
Unknown Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection.
| S-EPMC7920668 | biostudies-literature
Unknown Humoral immune response after different SARS-CoV-2 vaccination regimens.
| S-EPMC8776512 | biostudies-literature
Unknown Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL).
| S-EPMC8708153 | biostudies-literature
Unknown Humoral and adaptive immune responses to the SARS-CoV-2 vaccine.
| S-EPMC9214824 | biostudies-literature